STGN Stratagene Corp (MM)

Stratagene Corporation (NASDAQ:STGN) today announced that it will present at the Pacific Growth Equities Life Sciences Growth Conference, which will take place at the InterContinental Mark Hopkins Hotel in San Francisco on Tuesday, June 13, 2006. The presentation, which is scheduled for 12:30 p.m. Pacific Time, will include a review of the Company's business strategy and historical financial results. A live audio-only webcast of the presentation will be broadcast via the internet. Those interested in listening to the webcast will find a link to the webcast registration page on Stratagene's website, www.stratagene.com. An archived replay of the presentation will also be available approximately one hour following the live presentation and may be accessed at www.stratagene.com. About Stratagene Corporation Stratagene is a developer, marketer and manufacturer of specialized life science research and diagnostic products. The Company's life science research unit supports advances in science by inventing, manufacturing and distributing products that simplify, accelerate and improve research. These products are used throughout the academic, industrial and government research sectors in fields spanning molecular biology, genomics, proteomics, drug discovery and toxicology. The Company's diagnostic unit develops and manufactures products for urinalysis, and high quality automated instrument and reagent systems that use blood samples to test for more than 1,000 different allergies and autoimmune disorders. In addition, by combining its expertise in diagnostics and molecular biology, as well as its experience with FDA regulatory procedures, the Company is pursuing opportunities to expand its product portfolio to include molecular diagnostic kits and instrumentation. More information is available at www.stratagene.com.